Intellipharmaceutics International Inc. (IPCI)

[Tekterra]

Short term, this likely revisit the 0.8s and potentially bounce again to 1$ for that trade. If they kill this and delist from NASDAQ, it kills the trade too.

Unfortunately the stock got diluted however small the offering might be. More shares out for the same market value. This might have a hard time keeping that 1.10 floor. IPCI needs approval news bad.

However, longer term, things don't look that bad. Unless MNK unexpectedly ends the deal somehow , Seroquel revenue should steady increase come 2018. They might get to break even but another ANDA approval is actually more important than Rexista right now. The stock needs to that moral boost.

Originally, we were hoping for another approval some times year end, hoping that still holds true. There were two approvals from the year of 2016 if I am not mistaken. Just seems like it's overdue for one more either before year end or early 2018.